36 related articles for article (PubMed ID: 16264850)
21. Cetuximab plus irinotecan in refractory colorectal cancer patients.
Gil Delgado M; Spano JP; Khayat D
Expert Rev Anticancer Ther; 2007 Apr; 7(4):407-13. PubMed ID: 17428161
[TBL] [Abstract][Full Text] [Related]
22. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
Moosmann N; Heinemann V
Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070
[TBL] [Abstract][Full Text] [Related]
23. [New therapy options in colorectal carcinoma].
Folprecht G; Köhne CH
Ther Umsch; 2004 Jun; 61(6):373-8. PubMed ID: 15253162
[TBL] [Abstract][Full Text] [Related]
24. [Cetuximab].
Takiuchi H
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1192-5. PubMed ID: 17687200
[TBL] [Abstract][Full Text] [Related]
25. Metachronous metastasis to the penis from a rectal adenocarcinoma.
Ketata S; Boulaire JL; Soulimane B; Bargain A
Clin Colorectal Cancer; 2007 Sep; 6(9):657-9. PubMed ID: 17945039
[TBL] [Abstract][Full Text] [Related]
26. Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
Lee D
Clin Colorectal Cancer; 2004 Sep; 4(3):159-62. PubMed ID: 15377399
[No Abstract] [Full Text] [Related]
27. The handling of metastatic colorectal cancer.
Fornarini G; Guglielmi A; Sobrero A
Ann Oncol; 2005; 16 Suppl 2():ii141-3. PubMed ID: 15958445
[No Abstract] [Full Text] [Related]
28. Review: lapatinib in metastatic colorectal cancer-another strategy for disease control?
Kenny LM; Lam EW
Clin Adv Hematol Oncol; 2011 Jun; 9(6):500-1. PubMed ID: 21841752
[No Abstract] [Full Text] [Related]
29. The management of colorectal cancer: chemotherapy.
Ross PJ; Cunningham D
Crit Rev Oncol Hematol; 1999 May; 30(3):215-26. PubMed ID: 10439067
[No Abstract] [Full Text] [Related]
30. Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
Saltz LB
Nat Clin Pract Oncol; 2005 Jan; 2(1):20-1. PubMed ID: 16264850
[No Abstract] [Full Text] [Related]
31. [Application of monoclonal antibody in combination with irinotecan in the treatment of colorectal cancer].
Li J
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):796-7. PubMed ID: 17366800
[No Abstract] [Full Text] [Related]
32. New combinations in metastatic colorectal cancer: what are our expectations?
Hurwitz H
Oncologist; 2005 May; 10(5):320-2. PubMed ID: 15851788
[No Abstract] [Full Text] [Related]
33. Second-line treatment of patients with metastatic colorectal cancer.
Rougier P; Lepere C
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S48-54. PubMed ID: 16399432
[TBL] [Abstract][Full Text] [Related]
34. [Recent results of irinotecan therapy in colorectal cancer].
Láng I; Hitre E
Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
[TBL] [Abstract][Full Text] [Related]
35. Critical evaluation of current treatments in metastatic colorectal cancer.
Venook A
Oncologist; 2005 Apr; 10(4):250-61. PubMed ID: 15821245
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
